With "creative practice" as a keyword, we are constantly reevaluating our quality assurance system.
Our company started with the production of methyl ephedrine, an active pharmaceutical ingredient (API) for expectorants. The manufacturing of APIs and their quality control are the very roots of Tateyama Chemical. Aiming for world-class quality assurance, we achieve global-level quality assurance that complies not only with Japan's GMP, which is the standard for pharmaceutical manufacturing and quality control, but also with PIC/S GMP, to supply safe, effective, and high-quality pharmaceuticals to countries around the world. To respond to the trust of various customers and ultimately the end users, we will continuously update our quality control system. 【Management Policy】 ■ Development of new products ■ Refinement of technology ■ Thorough implementation of 5S and quality control ■ Raising awareness of environmental conservation and health and safety *For more details, please refer to the PDF materials or feel free to contact us.
Inquire About This Product
basic information
For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
We, Tateyama Kasei Co., Ltd., started our production in 1953 with methyl ephedrine. Currently, we manufacture a wide range of organic compounds such as pharmaceutical raw materials, pharmaceutical intermediates, and electronic materials under a thorough quality control and quality assurance system backed by ISO 9001 and c-GMP. In 2006, we also experienced an FDA inspection for API manufacturing. As international demands for quality control and assurance continue to rise, we aim to provide truly valuable products to users around the world. Additionally, to protect the global environment, we are enhancing efficient production technologies and appropriate pollution control facilities, while considering safety, health, and environmental conservation. We are always focused on quality, responsiveness, and the environment, with the development of high value-added products as our top priority for further growth.
![[Column] Management Strategies for Starting Materials in Active Pharmaceutical Ingredients](https://image.mono.ipros.com/public/product/image/3e5/2000710289/IPROS06292587954207697823.png?w=280&h=280)
